QC
GILD icon

Quent Capital’s Gilead Sciences GILD Stock Holding History

Quent Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Sell
3,526
-292
-8% -$40.9K 0.03% 209
2025
Q4 		$469K Buy
3,818
+229
+6% +$27.8K 0.03% 229
2025
Q3 		$398K Sell
3,589
-170
-5% -$19.3K 0.03% 173
2025
Q2 		$417K Buy
3,759
+919
+32% +$97.8K 0.04% 169
2025
Q1 		$318K Buy
2,840
+123
+5% +$12.7K 0.03% 188
2024
Q4 		$251K Buy
2,717
+811
+43% +$73K 0.03% 219
2024
Q3 		$160K Buy
1,906
+3
+0.2% +$229 0.02% 390
2024
Q2 		$131K Buy
1,903
+65
+4% +$4.34K 0.01% 401
2024
Q1 		$135K Sell
1,838
-2
-0.1% -$154 0.02% 415
2023
Q4 		$149K Sell
1,840
-220
-11% -$17.1K 0.02% 361
2023
Q3 		$154K Sell
2,060
-165
-7% -$12.7K 0.02% 323
2023
Q2 		$171K Buy
2,225
+87
+4% +$6.94K 0.03% 309
2023
Q1 		$177K Buy
2,138
+471
+28% +$39K 0.03% 304
2022
Q4 		$143K Buy
1,667
+57
+4% +$4.51K 0.03% 330
2022
Q3 		$99K Buy
1,610
+329
+26% +$20.7K 0.02% 377
2022
Q2 		$79K Buy
1,281
+50
+4% +$3.1K 0.02% 402
2022
Q1 		$73K Buy
1,231
+119
+11% +$7.61K 0.01% 494
2021
Q4 		$81K Buy
+1,112
New +$76.6K 0.02% 444

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Quent Capital's GILD Position: Q1 2026 in Review

Quent Capital reduced its Gilead Sciences (GILD) stake by 7.6% in Q1 2026, selling an estimated $40.9K and leaving 3,526 shares worth $491K. The position accounts for 0.03% of the portfolio, ranked #209.

Quent Capital first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Quent Capital held 3,526 shares of Gilead Sciences worth $491K as of Q1 2026.
  • Quent Capital sold 292 Gilead Sciences shares in Q1 2026, an estimated $40.9K.
  • Gilead Sciences made up 0.03% of Quent Capital's portfolio in Q1 2026, its #209 holding.
  • Quent Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.